emergency use

New Delhi: Pfizer has decided to withdraw the application for emergency use authorisation of its COVID-19 vaccine in India, the pharmaceutical major said on Friday. Incidentally, the US company was the first firm to seek the emergency use…

With traces of Favipiravir drug having been found in sperm and breast milk, FabiFlu (brand name of Favipiravir) must be used with great caution for COVID-19 treatment. It has been approved for marketing and sales in India for treating mild…